ViviGen MIS, reportedly the world’s only viable bone matrix to provide lineage-committed bone cells, is now available for use in trauma procedures. The product has been used effectively in MIS spine procedures.
ViviGen MIS includes both a pre-filled cannula and a sterile delivery device. This device allows ViviGen, a viable bone allograft, to be delivered with efficiency, reliability and precision. ViviGen MIS is provided by LifeNet Health.
In a comparison study with a bone graft funnel, ViviGen MIS offered substantially better graft preparation and delivery performance resulting in a more than 3x faster total procedure time. ViviGen MIS was the preferred delivery device in terms of ergonomics, ease of use, complications with delivery of the graft material, ease of positioning the delivery device and the exactness of graft delivery to the intended location.
Published data illustrates the clinical advantages of ViviGen. Studies have shown that it supports fusion rates as high as 98% even in complex, multi-level fusions while also being associated with significantly lower hospital charges than other grafting solutions.
ViviGen MIS, reportedly the world's only viable bone matrix to provide lineage-committed bone cells, is now available for use in trauma procedures. The product has been used effectively in MIS spine procedures.
ViviGen MIS includes both a pre-filled cannula and a sterile delivery device. This device allows ViviGen, a viable bone allograft, to...
ViviGen MIS, reportedly the world’s only viable bone matrix to provide lineage-committed bone cells, is now available for use in trauma procedures. The product has been used effectively in MIS spine procedures.
ViviGen MIS includes both a pre-filled cannula and a sterile delivery device. This device allows ViviGen, a viable bone allograft, to be delivered with efficiency, reliability and precision. ViviGen MIS is provided by LifeNet Health.
In a comparison study with a bone graft funnel, ViviGen MIS offered substantially better graft preparation and delivery performance resulting in a more than 3x faster total procedure time. ViviGen MIS was the preferred delivery device in terms of ergonomics, ease of use, complications with delivery of the graft material, ease of positioning the delivery device and the exactness of graft delivery to the intended location.
Published data illustrates the clinical advantages of ViviGen. Studies have shown that it supports fusion rates as high as 98% even in complex, multi-level fusions while also being associated with significantly lower hospital charges than other grafting solutions.
Copy to clipboard 
